Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Thiamet G and O-GlcNAcase Inhibition: Precision Tools for Pr
2026-07-29
Explore how Thiamet G, a leading O-GlcNAcase inhibitor, enables targeted modulation of cellular O-GlcNAc levels, unlocking new experimental strategies in metabolism and disease research. This article uniquely integrates recent findings on O-GlcNAcylation’s metabolic control, providing actionable insights for advanced assay design.
-
Adefovir Pharmacokinetics as an OAT1 Probe: Modeling & Impli
2026-07-29
This study applies population pharmacokinetic modeling to clarify adefovir’s behavior as an OAT1 probe within a clinical transporter phenotyping cocktail. The findings reveal that co-administration with other transporter substrates modestly affects absorption and bioavailability but leaves renal elimination—key for OAT1 activity assessment—unchanged, supporting adefovir’s specificity and reliability in such workflows.
-
AP-2α Suppresses MGMT to Reverse TMZ Resistance in Recurrent
2026-07-28
The referenced study demonstrates that AP-2α downregulates MGMT expression, thereby overcoming temozolomide (TMZ) resistance in recurrent glioblastoma by enhancing DNA damage. These mechanistic findings provide a promising avenue for improving chemotherapy efficacy in aggressive brain tumors.
-
Cyclo (-RGDfC) for Integrin-Targeted Hydrogel Assays: Protoc
2026-07-28
Cyclo (-RGDfC) empowers high-throughput, integrin-specific cell adhesion and migration studies, especially when paired with advanced hydrogel printing platforms. This guide translates cutting-edge research into actionable protocols, troubleshooting, and workflow enhancements for cancer and angiogenesis research.
-
Protein A/G Magnetic Co-IP/IP Kit: Precision in Protein Comp
2026-07-27
The Protein A/G Magnetic Co-IP/IP Kit streamlines co-immunoprecipitation for reliable protein-protein interaction analysis, leveraging recombinant Protein A/G magnetic beads for optimal specificity and yield. Its robust workflow, compatibility with advanced downstream applications, and troubleshooting flexibility make it a top choice for researchers dissecting complex interactomes.
-
PDHA1 Succinylation Drives Immune Escape in Cholangiocarcino
2026-07-27
This study demonstrates that succinylation of PDHA1 at lysine 83 in cholangiocarcinoma cells alters metabolic flux, leading to alpha-ketoglutaric acid accumulation and suppression of macrophage antigen presentation. These findings reveal a metabolic-immune axis underlying chemotherapy resistance and suggest PDHA1 succinylation as a promising therapeutic target.
-
BFH772 (VEGFR2 inhibitor): Technical Use and Protocol Guidan
2026-07-26
BFH772 is a potent, selective VEGFR2 inhibitor designed for research requiring precise modulation of VEGFR2-driven angiogenesis, especially in tumor models. It is best suited for workflows that do not require water solubility or broad-spectrum kinase inhibition, and its use should be guided by its defined selectivity and solubility characteristics.
-
WST-8 Glucose Uptake Assay Kit: Precision for Metabolic Anal
2026-07-25
The WST-8 Glucose Uptake Assay Kit empowers researchers with rapid, non-radioactive quantification of cellular glucose uptake—crucial for dissecting metabolic disease mechanisms. Its robust workflow and exceptional linearity make it indispensable for metabolic, diabetes, and hepatic research where sensitivity and reproducibility are paramount.
-
Pcbp1 Regulates Mitochondrial Integrity for B Cell Antibody
2026-07-24
The referenced study identifies the RNA binding protein Pcbp1 as a key regulator of mitochondrial integrity in B cells, linking its posttranscriptional control of Fdxr mRNA to efficient antibody production and germinal center responses. These findings advance understanding of how mitochondrial dynamics and protein synthesis are coordinated during humoral immunity.
-
GST-Driven Resistance Mechanisms to Lambda-Cyhalothrin in M.
2026-07-24
This study demonstrates that glutathione S-transferase (GST) is pivotal in conferring resistance to lambda-cyhalothrin in Megalurothrips usitatus by enhancing antioxidant defense systems. Targeted inhibition of GST with diethyl maleate dramatically increases insecticide sensitivity, providing mechanistic insight for pest resistance management strategies.
-
Rhodamine 123 (chloride): Next-Generation Tool for Transport
2026-07-23
Explore how Rhodamine 123 (chloride) enables advanced membrane transport process analysis and multidrug resistance research. This in-depth review highlights unique mechanistic insights, assay optimization, and data interpretation advances for ABC transporter and OATP1A2 research.
-
Safe DNA Gel Stain: Practical Guidance for Nucleic Acid Dete
2026-07-23
Safe DNA Gel Stain (SKU A8743) addresses the safety and workflow challenges of conventional nucleic acid stains by reducing mutagenic risks and UV exposure in DNA and RNA gel analysis. It is well-suited for standard molecular biology workflows employing agarose or polyacrylamide gels, but is less effective for low molecular weight DNA fragments (100–200 bp) and is strictly for research use only.
-
Safe DNA Gel Stain: High-Sensitivity, Less Mutagenic DNA Vis
2026-07-22
Safe DNA Gel Stain is a high-sensitivity DNA and RNA gel stain offering a safer, less mutagenic alternative to ethidium bromide. It enables nucleic acid visualization with blue-light or UV excitation, reducing DNA damage and enhancing cloning efficiency in molecular biology workflows.
-
Canagliflozin Enhances Mitochondrial Remodeling in Diabetic
2026-07-22
This study demonstrates that canagliflozin, an SGLT2 inhibitor, promotes structural and functional improvements in proximal tubular cell mitochondria in hypertensive–diabetic mice. These findings highlight a mitochondrial mechanism contributing to the renal protective effects of SGLT2 inhibition, informing future research on diabetic kidney disease pathogenesis and therapy.
-
Technical Guidance: Angiotensin I/II (1-5) Use in RAS Resear
2026-07-21
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide for reliable modeling of blood pressure regulation and aldosterone signaling in cardiovascular and renal research. It is not suitable for studies outside the renin-angiotensin system or unrelated peptide pathways due to its narrow mechanistic and solubility profile.